End-of-day quote
Other stock markets
|
||
- SEK | - |
07-02 | IRLAB Therapeutics AB Announces Phase IIb Study of Pirepemat Can Proceed as Planned After Positive Opinion from External Safety Committee | CI |
05-27 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
- Stock Market
- Equities
- IRLAB A Stock
- Stock
- News IRLAB Therapeutics AB